Global Vertinary Pain Management Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Devices;

Laser Therapy Devices, and Electromagnetic Therapy Devices.

By Product;

Drugs-NSAIDs, Opioids.

By Distribution Channel;

Veterinary Hospitals & Clinics, and Pharmacy.

By Application;

Joint Pain, Cancer.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn370062610 Published Date: March, 2025 Updated Date: April, 2025

Introduction

Global Vertinary Pain Management Market (USD Million), 2021 - 2031

In the year 2024, the Global Vertinary Pain Management Market was valued at USD 1,525.44 million. The size of this market is expected to increase to USD 2,428.76 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.9%.

The global veterinary pain management market is experiencing a significant surge in demand owing to several factors, including the growing awareness about pet health, advancements in veterinary medicine, and the increasing pet ownership worldwide. As more pet owners prioritize the well-being of their furry companions, the need for effective pain management solutions for animals becomes paramount. Veterinary pain management encompasses a wide range of products and techniques aimed at alleviating pain and discomfort in animals, spanning from traditional pharmaceuticals to alternative therapies like acupuncture and physical rehabilitation.

The growth of the global veterinary pain management market is the rise in pet population, particularly in developed regions. With pets increasingly being considered as integral members of the family, there's a heightened focus on ensuring their comfort and quality of life. This shift in mindset has led to a surge in demand for veterinary pain relief products and services, driving innovation and expansion within the market. Additionally, advancements in veterinary medicine, including the development of novel pain management drugs and therapies, are further fueling market growth.

The growing prevalence of chronic diseases and age-related conditions in companion animals is amplifying the need for effective pain management solutions. Conditions such as osteoarthritis, cancer, and degenerative joint diseases are becoming more common in pets, necessitating comprehensive pain management strategies to improve their overall well-being and longevity. Consequently, veterinary practitioners are increasingly integrating multimodal approaches to pain management, combining pharmaceuticals, nutraceuticals, and complementary therapies to provide tailored care for their patients. This trend is expected to continue driving the expansion of the global veterinary pain management market in the foreseeable future.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Devices
    2. Market Snapshot, By Product
    3. Market Snapshot, By Distribution Channel
    4. Market Snapshot, By Application
    5. Market Snapshot, By Region
  4. Global Vertinary Pain Management Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Pet Ownership Growth
        2. Increasing Awareness of Animal Welfare
        3. Rising Prevalence of Chronic Conditions in Pets
      2. Restraints
        1. High Cost of Advanced Treatments
        2. Limited Access to Veterinary Care in Rural Areas
        3. Resistance to Change in Traditional Practices
      3. Opportunities
        1. Expansion of Veterinary Healthcare Services
        2. Development of Novel Pain Management Therapies
        3. Adoption of Multimodal Pain Management Approaches
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Vertinary Pain Management Market, By Devices, 2021 - 2031 (USD Million)
      1. Laser Therapy Devices
      2. Electromagnetic Therapy Devices
    2. Global Vertinary Pain Management Market, By Product, 2021 - 2031 (USD Million)
      1. Laser Therapy Devices
      2. Electromagnetic Therapy Devices
    3. Global Vertinary Pain Management Market, By Distribution Channel, 2021 - 2031 (USD Million)
      1. Veterinary Hospitals & Clinics
      2. Pharmacy
    4. Global Vertinary Pain Management Market, By Application Channel, 2021 - 2031 (USD Million)
      1. Joint Pain
      2. Cancer
    5. Global Vertinary Pain Management Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Boehringer Ingelheim
      2. Zoetis
      3. Elanco
      4. Merck Animal Health
      5. Bayer
      6. Vetoquinol
      7. Norbrook Laboratories
      8. Ceva Sant Animale
      9. Dechra Pharmaceuticals
      10. Chanelle
      11. K-Laser USA
      12. Assisi Animal Health
  7. Analyst Views
  8. Future Outlook of the Market